Author:
Fetterly Gerald J.,Straubinger Robert M.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Guastalla JP, Lhomme C, Dauplat J, et al. Taxol (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma: an interim analysis of a Phase II multicenter study. Ann Oncol. 1994;5(suppl 6):S33–38.
2. Kubota T, Matsuzaki SW, Hoshiya Y, et al. Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice. J Surg Oncol. 1997;64:115–121.
3. Adler LM, Herzog TJ, Williams S, Rader JS, Mutch DG. Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines. Cancer. 1994;74:1891–1898.
4. Sharma A, Mayhew E, Straubinger RM. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res. 1993;53:5877–5881.
5. Murphy WK, Fossella FV, Winn RJ, et al. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst. 1993;85:384–388.
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献